Literature DB >> 25291680

CD5-positive B cells in rheumatoid arthritis and chronic lymphocytic leukemia.

P M Lydyard1, P Y Youinou2, A Cooke1.   

Abstract

Entities:  

Year:  1987        PMID： 25291680     DOI： 10.1016/0167-5699(87)90235-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  5 in total

1.  Establishment and characterization of new B-cell precursor leukemia cell line NALM-35.

Authors:  Yoshinobu Matsuo; Hans G Drexler; Akira Harashima; Nobuharu Fujii; Fumihiko Ishimaru; Kunzo Orita
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

Review 2.  Idiotypes and the structural diversity of human rheumatoid factors.

Authors:  S Fong; P P Chen; J J Crowley; G J Silverman; D A Carson
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatic diseases.

Authors:  J A Sowden; P J Roberts-Thomson; H Zola
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

4.  Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia.

Authors:  Cengiz Demir; Erdal Kara; Ömer Ekinci; Senar Ebinç
Journal:  Med Sci Monit       Date:  2017-05-05

5.  Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.

Authors:  Jose Manuel Sánchez-Maldonado; Rafael Cáliz; Miguel Ángel López-Nevot; Antonio José Cabrera-Serrano; Ana Moñiz-Díez; Helena Canhão; Rob Ter Horst; Luca Quartuccio; Signe B Sorensen; Bente Glintborg; Merete L Hetland; Ileana Filipescu; Eva Pérez-Pampin; Pablo Conesa-Zamora; Jerzy Swierkot; Alfons A den Broeder; Salvatore De Vita; Eva Rabing Brix Petersen; Yang Li; Miguel A Ferrer; Alejandro Escudero; Mihai G Netea; Marieke J H Coenen; Vibeke Andersen; João E Fonseca; Manuel Jurado; Katarzyna Bogunia-Kubik; Eduardo Collantes; Juan Sainz
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.